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Summary Background. Contact allergy to fragrances is common, and impairs quality of life,
particularly in young women.
Objective. To provide current results on the prevalences of sensitization to fragrance
allergens used as markers in the baseline series of most European countries.
Methods. Data of patients consecutively patch tested between 2009 and 2012 in 12
European countries with fragrance allergens contained in the baseline series were col-
lected by the European Surveillance System on Contact Allergies network and descrip-
tively analysed. Four departments used the TRUE Test® system.
Results. The ‘basic markers’ were tested on 51477 [fragrance mix II (FM II)] to 57123
[Myroxylon pereirae, balsam of Peru] patients, and yielded positive reactions as follows:
fragrance mix I 6.9%, Myroxylon pereirae 5.4%, FM II 3.8%, colophonium 2.6%, and
hydroxyisohexyl 3-cyclohexene carboxaldehyde 1.7%, with some regional differences.
Prevalences with TRUE Test® allergens were lower. Additional fragrances were tested
on 3643 (trimethylbenzenepropanol) to 14071 (oil of turpentine) patients, and yielded
between2.6% (Cananga odorata) and0.7% (trimethylbenzenepropanol) positive reactions.
Conclusions. Contact allergy to fragrances is common throughout Europe, with
regional variation probably being explained by patch test technique, and differences in
exposure and referral patterns. The current basic markers of fragrance sensitivity in the
baseline series should be supplemented with additional fragrance allergens.
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Contact allergy to fragrances is quite frequent, affect-
ing between 1.1% and 2.3% of the general population
in Europe (1). Quality of life is considerably impaired in
youngwomen, and especially if sensitizations aremultiple
andof highdegree (2). Cosmetics are the dominant causes
of sensitization, but other exposures have also been doc-
umented: topical medications, household products, aro-
matherapy materials, and occupationally used materials
(3–5). Recent studies have proven that fragrance mix
I (FM I), fragrance mix II (FM II) and the widely used
hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC)
are valuable screening tools for the detection of fragrance
sensitivity (6–11). However, both mixes contain only a
total of 14 substances, and, considering the wide array of
materials used for perfuming, it is not surprising that not
all cases of contact allergy to fragrances are identified by
the twomixes. Therefore, an oldermarker, namelyMyrox-
ylon pereirae [balsamofPeru], is still present in thebaseline
series. AlthoughM. pereirae is supposedly not used in per-
fumes, according to the recommendations of theResearch
Institute of Fragrance Materials, but only extracts and
distillates thereof (12), this natural resin contains many
chemicals that are constituents of perfumes and have sen-
sitizing potential (e. g. cinnamon compounds, benzoic
acid, and farnesol). Other materials, such as oil of turpen-
tine and colophonium, have been shown to be associated
with higher reactivity in fragrance-sensitive individuals,
albeit to a lesser degree thanM. pereirae (13, 14). Further-
more, studies with essential oils have shown that addi-
tional cases of fragrance sensitivity can be identified by
testing with them (15, 16).
Following a previous study of the European Surveil-
lance System on Contact Allergies (ESSCA) network
(17), we extended the European baseline series with
three essential oils and with the fragrance chemical
trimethylbenzenepropanol (Majantol®) in some depart-
ments, based on recent reports on relevant sensitizations
(18, 19). In the following, the results of a 4-year period
are analysed, with the main focus on the prevalence of
sensitization and regional differences throughout Europe.
Methods
The retrospective analysis is based on data collected by
the ESSCA (www.essca-dc.org) network. The ESSCA net-
work has been described in previous publications (17).
Briefly, clinical and demographic data, along with patch
test results, of all patients patch tested in the departments
participating in the ESSCA network for suspected aller-
gic contact dermatitis are documented electronically in
the local departments, with diverse data capture software
and, partly, the multilingual software WINALLDAT/ESSCA
provided by the ESSCA network (20). Patch testing was
performed according to international recommendations
(21). Data were pooled in the ESSCA network data centre
in Erlangen for further analysiswith R (version3.1.1) soft-
ware (22). Pertinent guidelines for the analysis of patch
test data (23) were considered. Reactions designated as
either+,++ or+++were classified as positive. The study
period was January 2009 to December 2012, and the
study included 12 European countries and, in total, 53
departments. A further description of this clinical sample
can be found in (24).
Test results with the TRUE Test® baseline series are
presented separately, for better comparability. Altogether,
63 530 consultations have been registered. Patients not
tested with the baseline series (for example, because of
a recent, valid test shortly before) were not considered
further in this analysis focusing on baseline series aller-
gens. Altogether, 59 922 consultations involved the base-
line series and at least one reading at days 3–5 after appli-
cation of patch tests. Because of multiple consultations
of some patients in the study period, all involving testing
with the baseline series, this number is further slightly
reduced to 59728 single consultations of these patients
(the most recent consultation was chosen for analysis).
Petrolatum-based allergens
The fragrance allergens and test concentration are shown
in Table 1. Only the first five materials are included in the
Europeanbaseline series as tested inmost European coun-
tries. Oil of turpentine has been included in the German
baseline series for many years, according to the recom-
mendation of the German Contact Dermatitis Research
Group. The essential oils jasmine absolute, sandalwood oil
and ylang-ylang oil were added to the German baseline
series in 2010 after a multicentre study (16). Trimethyl-
benzenepropanol has been added to the ‘monitor series’
in some German departments, in order to obtain current
data on sensitization, after two reports in the literature
(18, 19). In this study, it was also tested in Switzerland,
Spain, Finland, Lithuania and Poland at some points in
the period of analysis. At present, the European baseline
series does not include sorbitan sesquioleate, and very few
local baseline series do so. Hence, positive reactions to FM
I may, to a small extent, be attributable to contact allergy
to sorbitan sesquioleate, which is used as an emulsifier for
the mix (25, 26). A corresponding overestimation of the
proportion of true positive reactions to FM I may there-
fore have occurred in the present analyses. All fragrance
allergens were tested on consecutive patients. Stratifica-
tion for departments and further details on the basic char-
acteristics of this ESSCA network study are given else-
where (24). For the analysis, only patch test readings that
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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were positive (≥1+) at day 3 (or days 4 or 5) were consid-
ered; non-positive results comprised negative, irritant and
doubtful reactions.
TRUE Test®
The vast majority of patients were tested with pet.-based
allergens and investigator-loaded chamber systems. In
only 2435 consultations of consecutive patients were
patch testswith the TRUETest® performed, in four depart-
ments altogether [most patients were tested in Groningen
(n=1468; the three available allergens were exclusively
tested with the TRUE Test® in this department), followed
by Madrid Princesa (n=604), and some further patients
in Amsterdam, Murcia, and León].
Results
The overall results obtained with the 10 fragrance aller-
gens in pet. are shown in Table 1, including stratification
by sex and age (dichotomized). The proportion of males
aged <40 years age was 13.1%, and that of females was
27.0%; the proportions of patients aged ≥40 years were
20.5% in males and 39.4% in females; for further details,
see (24). FM I produced the highest prevalence of sensi-
tization in 56813 tested patients, in terms of 6.9% pos-
itive reactions (age-standardized and sex-standardized).
M. pereirae followed closely (5.4%); the remaining three of
the ‘basic markers’ produced lower prevalence rates, but
still well over 1% (FM II 3.8%, colophonium 2.6%, and
HICC 1.7%, respectively).
The other five materials were tested on smaller popu-
lations, ranging from 14071 (oil of turpentine) to 3643
(trimethylbenzenepropanol). The prevalence was highest
for ylang-ylang oil (Cananga odorata, 2.6%) and lowest
for trimethylbenzenepropanol (0.7%). The distribution of
reaction intensities is also shown in Table 1. In general,
1+ reactions were more frequent than ++ or +++ reac-
tions, particularly in the case ofM. pereirae and the essen-
tial oils. Irritant or doubtful reactions ranged around 2%,
without any obvious pattern.
Table 2 provides data on the prevalence of sensitization
to all 10 test materials stratified for the 12 European
countries. Differences were marked, with the highest
values being seen for FM I in Austria, Switzerland, and
The Netherlands (range 13.6 to 11.1%), as compared
with 3.8–4.9% in Lithuania, Italy, and Spain. However,
in Lithuania only 865 patients were tested.
For FM II, the figureswere lower, generally being<10%
(range7.27 to1.31%).Regional differences corresponded
to those of FM I, with the exception of Lithuania (where
the prevalence rates of FM I and FM II were nearly the
same). HICC reached a prevalence of sensitization of>1%
in all countries, thus justifying its place in the European
baseline series; the distribution pattern among the par-
ticipating countries was similar to that of FM II, which
contains HICC at 2.5% as the predominant constituent
upon breakdown testing. Concerning coupled reactivity
betweenFM II andHICC, 43074patientswere testedwith
both allergens. Of these, 578 reacted both to FM II and
to HICC, 1192 only to FM II, and 181 only to HICC. This
latter number corresponds to 0.42% of tested patients or
24% of all patients reacting to HICC.
The figures for M. pereirae and colophonium are in
line with previous observations, with the exception of
Lithuania, where colophonium had produced the high-
est value (5.6%) of all countries. Oil of turpentine reached
prevalence values of 1.3–3.1% in the four countries test-
ing it. The three essential oils were tested in three coun-
tries (Austria, Switzerland, and Germany) in considerable
numbers of patients, and the highest range was seen for
ylang-ylangoil (C. odorata; 2.4–4.5%); the figures for san-
dalwood oil (Santalum album) and jasmine absolute (Jas-
minum grandiflorum) were lower, but still>1%. Trimethyl-
benzenepropanolwas tested on small groups of patients in
six countries; only in Spain did the number tested exceed
1000 patients. The number of positive cases was low in
Germany, Finland, and Lithuania, being just above 1%. If
FM I, FM II and HICC are considered to be fragrance con-
tact allergy markers, the overall reactivity (to pet.-based
allergens) is 9.2%. If, additionally, M. pereirae resin and
oil of turpentine are considered to be markers, the overall
prevalence of positive patch test reactions to at least one
of these allergens increases to 12.7%.
The results obtained with the three fragrance aller-
gens in the TRUE Test® system are shown in Table 3. The
prevalence was highest for FM I (3.9%), and lower for
M. pereirae and colophonium (2.2% each). The distribu-
tion of reaction grades as compared with the pet.-based
allergens was slightly different in terms of a lower pro-
portion of irritant reactions/?+ and a higher share of +
reactions for the three TRUE Test® allergen preparations.
Discussion
The overall results show a rank order that is rather typical
of fragrance markers: FM I,M. pereirae, FM II, HICC, and
oil of turpentine (in descending frequency of positive
reactions). In a recent analysis of the German IVDK
network on over 130000 patients (1999–2012), with
overlap concerning about 13500 patients also included
in the present analysis, the rank order was very similar
(FM I 8.7%, M. pereirae 8.4%, FM II 4.9%, and oil of
turpentine 2.0%) (27). There is now abundant evidence
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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Table 2. Results obtained with the 10 fragrance allergens patch tested in petrolatum, stratified for country
Country n tested n positive % positive % pos. std. 95%CI
(a) Fragrance mix, 8% pet.
Austria 1113 163 14.65 13.63 11.57–15.69
Switzerland 5001 586 11.72 11.05 10.16–11.94
Germany 7364 671 9.11 8.36 7.7–9.02
Denmark 2547 219 8.6 7.75 5.98–9.51
Spain 3405 170 4.99 4.9 4.15–5.65
Finland 1056 74 7.01 6.81 5.3–8.33
Italy 9025 434 4.81 4.75 4.31–5.19
Lithuania 865 44 5.09 3.79 2.65–4.94
The Netherlands 2821 373 13.22 12.72 11.5–13.94
Poland 2826 148 5.24 5.1 4.28–5.91
Slovenia 5183 269 5.19 4.93 4.34–5.51
United Kingdom 15571 1028 6.6 6.23 5.85–6.6
(b) Fragrance mix II, 14% pet.
Austria 1113 87 7.82 7.27 5.71–8.83
Switzerland 5000 290 5.8 5.37 4.73–6
Germany 7406 386 5.21 4.77 4.27–5.28
Denmark 2554 137 5.36 4.8 3.38–6.22
Spain 3993 95 2.38 2.32 1.83–2.8
Finland 1057 35 3.31 3.23 2.17–4.3
Italy 1591 23 1.45 1.31 0.77–1.86
Lithuania 865 37 4.28 3.64 2.38–4.9
The Netherlands∗ 4274 279 6.53 6.31 5.58–7.03
Poland 2827 117 4.14 4.02 3.29–4.74
Slovenia 5197 144 2.77 2.73 2.28–3.18
United Kingdom 15579 447 2.87 2.76 (2.5–3.02)
(c) Hydroxyisohexyl 3-cyclohexene carboxaldehyde, 5% pet.
Austria 1109 33 2.98 2.5 1.63–3.36
Switzerland 4968 113 2.27 2.14 1.73–2.56
Germany 7435 190 2.56 2.4 2.03–2.77
Denmark 2555 65 2.54 2.35 1.33–3.36
Spain 3500 36 1.03 1.02 0.67–1.37
Finland 544 12 2.21 2.06 0.87–3.25
Italy 6750 76 1.13 1.13 0.88–1.39
Lithuania 865 12 1.39 1.18 0.47–1.89
The Netherlands 4275 97 2.27 2.18 1.75–2.61
Poland 2825 58 2.05 1.98 1.47–2.49
Slovenia 5212 70 1.34 1.27 0.97–1.57
United Kingdom 10616 145 1.37 1.33 1.11–1.55
(d) Myroxylon pereirae resin (balsam of Peru), 25% pet.
Austria 1109 142 12.8 11.63 9.75–13.5
Switzerland 4984 489 9.81 8.99 8.18–9.79
Germany 7409 588 7.94 6.77 6.19–7.34
Denmark 2560 114 4.45 3.78 2.58–4.97
Spain 3361 166 4.94 4.75 4.02–5.49
Finland 1052 70 6.65 6.2 4.79–7.61
Italy 9248 336 3.63 3.63 3.25–4.01
Lithuania 865 51 5.9 5.79 4.08–7.5
The Netherlands 2820 229 8.12 7.76 6.78–8.74
Poland 2827 163 5.77 5.53 4.69–6.37
Slovenia 5182 206 3.98 3.8 3.28–4.32
United Kingdom 15574 805 5.17 4.77 4.45–5.09
(e) Colophonium (colophony), 20% pet.
Austria 1113 54 4.85 4.78 3.43–6.13
Switzerland 5002 165 3.3 3.26 2.74–3.78
Germany 7475 326 4.36 4.08 3.6–4.56
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Table 2. continued
Country n tested n positive % positive % pos. std. 95%CI
Denmark 2552 85 3.33 3.31 2.06–4.57
Spain 3361 55 1.64 1.57 1.14–1.99
Finland 1052 45 4.28 4.03 2.87–5.19
Italy 9244 111 1.2 1.19 0.97–1.41
Lithuania 865 55 6.36 5.61 4.05–7.18
The Netherlands 2821 122 4.32 4.13 3.41–4.86
Poland 2827 50 1.77 1.68 1.21–2.15
Slovenia 5206 83 1.59 1.49 1.17–1.82
United Kingdom 15569 423 2.72 2.67 2.41–2.92
(f) Oil of turpentine, 10% pet.
Austria 1109 36 3.25 3.14 2.09–4.19
Switzerland 4972 85 1.71 1.62 1.26–1.98
Germany 7437 184 2.47 2.22 1.87–2.57
Finland 553 7 1.27 1.25 0.29–2.2
(g) Trimethylbenzenepropanol, 10% pet.
Switzerland 424 4 0.94 0.81 0–1.69
Germany 981 9 0.92 1.12 0.35–1.9
Spain 1316 4 0.3 0.33 0–0.66
Finland 490 7 1.43 1.19 0.29–2.09
Lithuania 130 2 1.54 1.37 0–3.3
Poland 302 1 0.33 0.28 0–0.84
(h) Cananga odorata extract (ylang-ylang oil), 10% pet.
Austria 1094 49 4.48 4.45 3.16–5.74
Switzerland 2962 83 2.8 2.87 2.21–3.53
Germany 5540 140 2.53 2.35 1.93–2.77
(i) Santalum album extract (sandalwood oil), 10% pet.
Austria 1094 32 2.93 2.9 1.85–3.95
Switzerland 2964 42 1.42 1.34 0.91–1.78
Germany 5540 77 1.39 1.36 1.03–1.69
(j) Jasminum spp. extract (jasmine absolute), 5% pet.
Austria 1094 33 3.02 2.56 1.67–3.45
Switzerland 2963 47 1.59 1.4 0.98–1.82
Germany 5544 101 1.82 1.61 1.28–1.95
95% CI, 95% confidence interval to the standardized prevalence; % pos. std., proportion of positives, directly age-standardized and
sex-standardized.
∗Groningen, 6.3%; Amsterdam-VU, 6.7% (crude) positive (p=0.66, 𝜒2 test).
Table 3. Overall results obtained with the three fragrance allergens available in the TRUE Test®
Allergen Concentration (mg/cm2) n tested % + % ++/+++ % ?+/IR % positive % pos. std. 95%CI
Fragrance mix 0.43 2362 2.96 0.97 0.94 3.94 3.72 2.97–4.48
Myroxolon pereirae resin (balsam of Peru) 0.8 2362 1.78 0.47 0.67 2.24 2.18 1.59–2.78
Colophonium (colophony) 0.85 2360 1.86 0.59 0.46 2.46 2.25 1.67–2.84
95% CI, 95% confidence interval to the standardized prevalence; IR, irritant reaction; % pos.std., proportion of positives, directly
age-standardized and sex-standardized.
that HICC is a relevant fragrance contact allergen, with
prevalence figures ranging from 1.5% to 2.6% (25). The
proportion of patients with a low degree of sensitiza-
tion seems to have increased – those patients may only
react to HICC 5% as tested separately in the European
baseline series, and may remain negative to FM II, which
contains HICC at the lower 2.5% concentration; the
proportion of patients with this pattern of reactivity
increased significantly, from 13.5% in 2005–2006 to
22.0% in 2013 (25). In the present analysis, 0.42% of all
patients reacted only to HICC 5% pet., corresponding to
24% of all patients reacting to HICC, thus confirming the
above finding.
Patients who are sensitive to M. pereirae are older
and suffer more frequently from leg dermatitis – topical
medications and remedies of various types containing
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natural resins are still, in some regions, the primary
causes of sensitization rather than cosmetics or fine
perfumes, which currently do not contain M. pereirae,
although they do containt distillates and extracts thereof
(12). M. pereirae-sensitive patients have often no positive
fragrance history, and show little overlap with patients
reacting positively to FM I, and even less overlap with
patients reacting positively to FM II (14); moreover, they
are substantially older than patients reacting positively
to the other fragrance markers (27), which may point to
(partly) historical sources of sensitization, as mentioned
above.
Combined positive reactions between the fragrance
markers (except for FM II and HICC) have not been anal-
ysed in this study, but have been reported by several
authors (11, 13, 25, 27). The degree of positive associ-
ations between the two classic markers (FM I and FM II,
respectively) and the natural resin mixtures decreases in
the orderM. pereirae, colophonium, and oil of turpentine.
AswithM. pereirae, sources other than fragrances are fre-
quent causes of sensitization, that is, occupational mate-
rials (glues, tapes, paints and varnishes, cooling fluids,
etc.) andnon-occupational products (household, hobbies,
etc.).
These factors influencing sensitization have to be con-
sidered in explaining the regional differences in the preva-
lence data. For FM I, FM II, and HICC, the high preva-
lences in Austria, Switzerland and The Netherlands are
probably attributable to the use of cosmetics, which have
relatively high concentrations of sensitizing fragrances.
On the other hand, in Italy and Spain, the prevalences
for these allergens were relatively low. Ethnic factors can-
not be fully excluded but, in all likelihood, differences in
exposure are responsible for this. Conversely, in Spain, an
unusually high rate of geraniol sensitivity has been traced
to the use of a medicament containing geraniol (28).
The three essential oils were tested in only three coun-
tries, and all showed prevalences of >1%, qualifying
them for inclusion in the baseline series. Ylang-ylang oil
produced the most positive reactions, in agreement with
previous studies (15, 16). The role of trimethylbenzene-
propanol as a fragrance sensitizer is still unclear, because
it was tested on a relatively low number of consecutive
patients, producing positive reactions in between 0.3%
and 1.4%. In a recent study from the United Kingdom on
1951 patients, trimethylbenzenepropanol was positive in
0.8% (29). Of the 15 positive cases, 7 also reacted to FM
I and 4 reacted to FM II. Furthermore, in this study, the
baseline series fragrance markers were extended with the
26 fragrance substances for which labelling is mandatory
in the EU. The constituents of FM I were tested at the
double concentration as present in the mix (except for
Evernia furfuracea and cinnamal). The prevalence rates
of positive reactions were 6.4% for FM I, 3.3% for FM
II, 3.5% for M. pereirae, 1.3% for HICC, and 2.7% for
colophonium. The last of these was not considered to be
a baseline fragrance marker by the authors. The single
fragrance allergens with the greatest contact allergy
frequencies were cinnamyl alcohol, E. furfuracea, and
isoeugenol. Of the 203 patients who reacted to any of the
26 fragrance marker in the baseline series, only 57.6%
also reacted to a fragrance marker in the baseline series:
52.7% reacted to either FM I or FM II, 13.8% reacted to
M. pereirae, and 6.4% reacted to HICC. These findings
show that the baseline fragrance markers should be sup-
plemented with other substances used by the fragrance
industry. However, so far, no further candidate among
the 26 substances to be labelled according to the present
regulation seems to qualify for inclusion in the baseline
series. Further patch test data from large multicentre
studies, confirmation of positive reactions by repeated
open application tests and information on sources of
sensitization are needed. In addition, recent findings
have indicated that oxidized forms of certain fragrances,
such as limonene and linalool, have a higher sensitizing
potential and should be preferred for diagnostic patch
testing (30).
The results obtained with the TRUE Test® point
towards an important technical detail. The prevalence
of positive reactions was relatively low for all three
allergens available in this system. Considering that
the majority of patients were tested in Groningen (The
Netherlands), the differences from the results obtained
with the pet.-based FM I and M. pereirae are striking.
The second test centre in The Netherlands was the Free
University department in Amsterdam, and provided
almost exclusively data obtained with pet.-based aller-
gens; it may therefore be responsible for the high figures
(for FM I, 12.7% of 2821 patients positive). In the two
departments, FM II was tested in pet. on 4274 patients,
as it is not available in the TRUE Test®. Interestingly,
with this pet.-based allergen, the sensitization prevalence
rates were very similar (see footnote to Table 2). This
may point to FM I of the TRUE Test® having lower sen-
sitivity for detecting contact allergy than the pet.-based
test system (31), although other explanations may also
be valid. In a study from Israel on 207 patients, the
concordance between various allergens tested with the
TRUE Test® and with investigator-loaded IQ Chambers™
was studied: high concordance was found for methyl-
choroisothiazolinone (MCI)/methylisothiazolinone (MI),
nickel sulfate, formaldehyde, and p-phenylenediamine
(81.5% to 72.7%), moderate concordance was found for
quaternium-15, potassium dichromate, and fragrance
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mix (66.7 to 58.1%), and low concordance was found for
cobalt chloride and M. pereirae (27.6 to 18.2%) (32). In
this study, among a group of 18 patients reacting to FM I
and ‘with demonstrated exposure’ (i.e. clinical relevance
to fragrances), 50% reacted to both IQ Chambers™
and the TRUE Test®, 44% reacted only to FM I IQ
Chambers™, and 6% reacted only to FM I TRUE Test®.
In another study on 167 patients in the United States,
the Finn Chambers® system was found to be superior in
detecting clinically relevant allergies to FM I,M. pereirae,
and thiuram mix, whereas the TRUE Test® was found
to be more sensitive for nickel, neomycin, and MCI/MI
(33). Therefore, patch test results may differ with the test
system used; for FM I in general, the TRUE Test® yields
lower reactivity with fewer irritant reactions, which is
also apparent in this study (and slightly better repro-
ducibility), but with the drawback of relevant contact
allergies being missed (see above) (31). Together, these
findings indicate that the TRUE Test® sensitivity for
screening fragrance contact allergy is definitely lower
than that of the pet.-based chamber system. The test
concentration of FM I in the TRUE Test® system has not
been changed since its inauguration, and needs to be
re-evaluated.
As mentioned in ‘Methods’, the emulsifier sorbitan
sesquioleate was not separately tested at 20% in the Euro-
pean baseline series. Therefore, the test results for FM I
(containing 5% sorbitan sesquioleate)may have to be cor-
rected by the exclusion of sorbitan sesquioleate-sensitive
patients. According to a recent study on 2952 patients
reacting positively to FM I, 5.4% reacted positively to 20%
sorbitan sesquioleate; the majority of positive reactions
to FM I in sorbitan sesquioleate-positive patients were not
attributable to fragrance constituents after breakdown
testing (25). In a previous multicentre study on 709
consecutive patients, the frequency of reactivity to 20%
sorbitan sesquioleate was only 0.7% (26). In order to val-
idate a positive reaction to FM I, it is therefore necessary
to test the emulsifier either initially as addition to the
European baseline series, or later when the breakdown
test with the single constituents is performed. However,
the overestimation of sensitization prevalence introduced
into the present analysis can be considered to be minor.
In conclusion, our data show that the basic fragrance
markers FM I, FM II and HICC yield positive reactions in
6.9 to 1.7% of consecutively tested patients, showing that
fragrance allergy is a common problem across Europe.
The three essential oils ylang-ylang oil, jasmine absolute
and sandalwood oil also yielded a rate of positive reac-
tions of >1%, and thus qualify for inclusion in the Euro-
pean baseline series. Labelling for these essential oils and
for a number of other important fragrance allergens, as
suggested by a recent SCCS opinion (5), is still lacking.
Hence, clinical relevance is difficult to evaluate, and aller-
gen avoidance is difficult to achieve. Regional differences
in the prevalence of sensitivity among European coun-
tries exist, and are most likely attributable to differences
in exposure and test populations.
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